gatifloxacin has been researched along with Alloxan Diabetes in 4 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gatifloxacin, a fluoroquinolone antimicrobial agent, has been reported to cause both hypoglycemia and hyperglycemia in diabetic and non-diabetic patients." | 7.76 | Gatifloxacin-induced histamine release and hyperglycemia in rats. ( Ishiwata, Y; Yasuhara, M, 2010) |
| "Gatifloxacin, a fluoroquinolone antimicrobial agent, has been reported to cause both hypoglycemia and hyperglycemia in diabetic and non-diabetic patients." | 3.76 | Gatifloxacin-induced histamine release and hyperglycemia in rats. ( Ishiwata, Y; Yasuhara, M, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagai, M | 1 |
| Nagata, S | 1 |
| Yamagishi, N | 1 |
| Satoh, H | 1 |
| Furuhama, K | 1 |
| Ishiwata, Y | 2 |
| Yasuhara, M | 2 |
| Yu, Y | 1 |
| Wang, X | 1 |
| Liu, C | 1 |
| Yao, D | 1 |
| Hu, M | 1 |
| Li, J | 1 |
| Hu, N | 1 |
| Liu, L | 1 |
| Liu, X | 1 |
| Sanada, Y | 1 |
4 other studies available for gatifloxacin and Alloxan Diabetes
| Article | Year |
|---|---|
Clinicopathological aspect of dysglycemia in naive and diabetic rats induced by the fluoroquinolone antibacterial gatifloxacin.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Blood Glucose; Diabetes Mellitus, Experimental | 2010 |
Gatifloxacin-induced histamine release and hyperglycemia in rats.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Blood Glucose; Diabetes Mellitus, Experimental | 2010 |
Combined contributions of over-secreted glucagon-like peptide 1 and suppressed insulin secretion to hyperglycemia induced by gatifloxacin in rats.
Topics: Animals; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; Fluoroquinolones; Gatifloxacin; | 2013 |
Effects of gatifloxacin on serum glucose concentration in normal and diabetic rats.
Topics: Animals; Anti-Bacterial Agents; Blood Glucose; Chromatography, High Pressure Liquid; Diabetes Mellit | 2006 |